CARL ZEISS MEDITEC ADR 1 (AFXA) — Tangible Net Worth Ratio
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Tangible Net Worth Ratio of 68.8% as of September 2025. This metric is calculated by deducting intangible assets (€662.87 Million) from net assets (€2.13 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore CARL ZEISS MEDITEC ADR 1 (AFXA) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
CARL ZEISS MEDITEC ADR 1 Tangible Net Worth Ratio (2022–2025)
This chart shows how CARL ZEISS MEDITEC ADR 1's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 68.8%, reflecting net assets of €2.13 Billion with intangible assets of €662.87 Million EUR. For live market cap and overall valuation, see AFXA stock market capitalisation.
Annual Tangible Net Worth Ratio for CARL ZEISS MEDITEC ADR 1 (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for CARL ZEISS MEDITEC ADR 1 from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore AFXA capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.8% | €2.13 Billion | €662.87 Million | €3.40 Billion | ▲ +3.2 pp |
| 2024 | 65.6% | €2.06 Billion | €706.85 Million | €3.39 Billion | ▼ -22.4 pp |
| 2023 | 88.1% | €2.17 Billion | €259.49 Million | €3.03 Billion | ▼ -0.1 pp |
| 2022 | 88.2% | €2.03 Billion | €240.43 Million | €2.82 Billion | — |